Kim Sigaloff

11.2k total citations
76 papers, 2.2k citations indexed

About

Kim Sigaloff is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Kim Sigaloff has authored 76 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Infectious Diseases, 37 papers in Virology and 20 papers in Epidemiology. Recurrent topics in Kim Sigaloff's work include HIV/AIDS Research and Interventions (44 papers), HIV/AIDS drug development and treatment (37 papers) and HIV Research and Treatment (37 papers). Kim Sigaloff is often cited by papers focused on HIV/AIDS Research and Interventions (44 papers), HIV/AIDS drug development and treatment (37 papers) and HIV Research and Treatment (37 papers). Kim Sigaloff collaborates with scholars based in Netherlands, Uganda and Nigeria. Kim Sigaloff's co-authors include Tobias F. Rinke de Wit, Raph L Hamers, Cissy Kityo, Wendy Stevens, Margaret Siwale, Kishor Mandaliya, Carole L. Wallis, Job C. J. Calis, Michèle van Vugt and T. Sonia Boender and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Kim Sigaloff

70 papers receiving 2.2k citations

Peers

Countries citing papers authored by Kim Sigaloff

Since Specialization

Citations

This map shows the geographic impact of Kim Sigaloff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Sigaloff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Sigaloff more than expected).

Fields of papers citing papers by Kim Sigaloff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim Sigaloff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Sigaloff. The network helps show where Kim Sigaloff may publish in the future.

Co-authorship network of co-authors of Kim Sigaloff

This figure shows the co-authorship network connecting the top 25 collaborators of Kim Sigaloff. A scholar is included among the top collaborators of Kim Sigaloff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim Sigaloff. Kim Sigaloff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	High Prevalence of Posttraumatic Stress Disorder Symptoms Found in Well-Treated People with HIV after the Introduction of Patient-Reported Outcome Measures 2025 ·AIDS and Behavior ·(unknown), Colette Smit, Pythia T. Nieuwkerk, (unknown), (unknown), Jeannine F. Nellen, Kim Sigaloff, Annouschka M. Weijsenfeld, Laura Laan, (unknown), Suzanne E. Geerlings, Marc van der Valk	0
2	Vertebral osteomyelitis in patients with infective endocarditis: prevalence, risk factors and mortality 2025 ·European Journal of Clinical Microbiology & Infectious Diseases ·(unknown), Kim Sigaloff, (unknown), M. G. J. Duffels, (unknown), Tjeerd Germans, Jiri F. P. Wagenaar, David T.P. Buis, Thomas W. van der Vaart, Cornelis H. van Werkhoven, Jan M. Prins, Victor A. Umans	0
3	Liver abscesses secondary to a non-O1/non-O139 Vibrio cholerae bacteremia acquired in a non-coastal area: a case report 2024 ·Annals of Clinical Microbiology and Antimicrobials ·(unknown), (unknown), Sébastien Matamoros, Kim Sigaloff	0
4	“Doctor, would it surprise you if there were prescribing errors in this patient's medication?” Identifying eligible patients for in‐hospital pharmacotherapeutic stewardship: A matched case‐control study 2024 ·British Journal of Clinical Pharmacology ·(unknown), Birgit I. Lissenberg‐Witte, Kim Sigaloff, Jelle Tichelaar, Michiel A. van Agtmael	1
5	Quality indicators for appropriate in‐hospital pharmacotherapeutic stewardship: An international modified Delphi study 2024 ·British Journal of Clinical Pharmacology ·(unknown), Jelle Tichelaar, Lidwine B. Mokkink, Kim Sigaloff, Michiel A. van Agtmael	1
6	The Dutch Working Party on Antibiotic Policy (SWAB) guideline for the approach to suspected antibiotic allergy 2023 ·Clinical Microbiology and Infection ·(unknown), (unknown), L. Bode, Maja Bulatović, (unknown), Masja Loogman, Suzanne P. M. Lutgens, (unknown), Chris Nieuwhof, (unknown), Jan W. Schoones, Kim Sigaloff, A. B. Sprikkelman, (unknown), Mark de Boer	17
7	Optimising HIV care using information obtained from PROMs: protocol for an observational study 2023 ·BMJ Open ·(unknown), Pythia T. Nieuwkerk, (unknown), Jeannine F. Nellen, Annouschka M. Weijsenfeld, Kim Sigaloff, Laura Laan, (unknown), (unknown), Lotte Haverman, Suzanne E. Geerlings, Marc van der Valk	1
8	The impact of the updated EORTC/MSG criteria on the classification of hematological patients with suspected invasive pulmonary aspergillosis 2022 ·Clinical Microbiology and Infection ·(unknown), Alex Wagemakers, Kim Sigaloff, Robin van Houdt, Nick de Jonge, Karin van Dijk	15
9	Improving indicator-condition guided testing for HIV in the hospital setting (PROTEST 2·0): A multicenter, interrupted time-series analysis 2022 ·The Lancet Regional Health - Europe ·(unknown), Maarten F. Schim van der Loeff, Anders Boyd, Udi Davidovich, Marc van der Valk, Kees Brinkman, Kim Sigaloff, Judith Branger, (unknown), Godelieve J. de Bree, Peter Reiss, Jan van Bergen, Suzanne E. Geerlings	10
10	Guidance of empirical antimicrobial therapy by surveillance cultures in high-risk neutropenic patients: a retrospective cohort study 2022 ·Antimicrobial Resistance and Infection Control ·(unknown), (unknown), Jennifer Huynh, Elske Sieswerda, Nick de Jonge, Karin van Dijk, Kim Sigaloff, Rogier P. Schade	8
11	Coronary stent infection 2021 ·European Heart Journal - Case Reports ·(unknown), Jasper L. Selder, Kim Sigaloff, (unknown)	2
12	Reducing the dosing frequency of selective digestive tract decontamination to three times daily provides effective decontamination of Gram-negative bacteria 2021 ·European Journal of Clinical Microbiology & Infectious Diseases ·(unknown), Kim Sigaloff, (unknown), Johan I. van der Spoel, Rogier P. Schade	3
13	HIV Drug Resistance Among Children Initiating First-Line Antiretroviral Treatment in Uganda 2016 ·AIDS Research and Human Retroviruses ·Cissy Kityo, Kim Sigaloff, T. Sonia Boender, Elizabeth Kaudha, Joshua Kayiwa, Victor Musiime, (unknown), Mary Kiconco, Immaculate Nankya, (unknown), Job C. J. Calis, Tobias F. Rinke de Wit, Peter Mugyenyi	31
14	Alarming increase in pretreatment HIV drug resistance in children living in sub-Saharan Africa: a systematic review and meta-analysis 2016 ·Journal of Antimicrobial Chemotherapy ·Ragna S. Boerma, Kim Sigaloff, Sulaimon Akanmu, Seth Inzaule, Michaël Boele van Hensbroek, Tobias F. Rinke de Wit, Job C. J. Calis	63
15	Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa 2016 ·The Journal of Infectious Diseases ·T. Sonia Boender, Raph L Hamers, Pascale Ondoa, Maureen Wellington, Cleophas Chimbetete, Margaret Siwale, (unknown), Sheila N. Balinda, Cissy Kityo, Titilope A. Adeyemo, Sulaimon Akanmu, Kishor Mandaliya, Mariëtte E. Botes, Wendy Stevens, Tobias F. Rinke de Wit, Kim Sigaloff	40
16	Patterns of HIV-1 Drug Resistance After First-Line Antiretroviral Therapy (ART) Failure in 6 Sub-Saharan African Countries: Implications for Second-Line ART Strategies 2012 ·Clinical Infectious Diseases ·Raph L Hamers, Kim Sigaloff, Annemarie M. J. Wensing, Carole L. Wallis, Cissy Kityo, Margaret Siwale, Kishor Mandaliya, Prudence Ive, (unknown), Melanie Wellington, Akin Osibogun, Wendy Stevens, Tobias F. Rinke de Wit, Rob Schuurman, (unknown)	137
17	Pre-exposure prophylaxis (PrEP) will have a limited impact on the prevalence of HIV-1 drug resistance in sub-Saharan Africa: comparison of mathematical models 2012 ·Journal of the International AIDS Society ·David van de Vijver, Brooke E Nichols, (unknown), Valentina Cambiano, (unknown), Robert Glaubius, Katrina Lythgoe, John W. Mellors, Andrew Phillips, Kim Sigaloff, Timothy B. Hallett	1
18	Unnecessary Antiretroviral Treatment Switches and Accumulation of HIV Resistance Mutations; Two Arguments for Viral Load Monitoring in Africa 2011 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Kim Sigaloff, Raph L Hamers, Carole L. Wallis, Cissy Kityo, Margaret Siwale, Prudence Ive, Mariëtte E. Botes, Kishor Mandaliya, Maureen Wellington, Akin Osibogun, Wendy Stevens, Michèle van Vugt, Tobias F. Rinke de Wit	151
19	Short Communication: High Prevalence of Transmitted Antiretroviral Drug Resistance Among Newly HIV Type 1 Diagnosed Adults in Mombasa, Kenya 2011 ·AIDS Research and Human Retroviruses ·Kim Sigaloff, Kishor Mandaliya, Raph L Hamers, (unknown), Irene Jao, (unknown), Brian Magambo, Anne Kapaata, Nicaise Ndembi, Tobias F. Rinke de Wit	33
20	HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study 2011 ·The Lancet Infectious Diseases ·Raph L Hamers, Carole L. Wallis, Cissy Kityo, Margaret Siwale, Kishor Mandaliya, Francesca Conradie, Mariëtte E. Botes, Maureen Wellington, Akin Osibogun, Kim Sigaloff, Immaculate Nankya, Rob Schuurman, Ferdinand W N M Wit, Wendy Stevens, Michèle van Vugt, Tobias F. Rinke de Wit	228

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact